Cargando…

Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world, causing severe morbidity and mortality. Since the first reports of Coronavirus disease 2019 (COVID-19) in late 2019, research on the characteristics of specific humoral immunity against SARS-CoV-2 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yajie, Zhu, Jiajie, Liu, Zongming, Li, Chaonan, Guo, Yikai, Wang, Ying, Chen, Keda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389018/ https://www.ncbi.nlm.nih.gov/pubmed/35990623 http://dx.doi.org/10.3389/fimmu.2022.864278

Ejemplares similares

Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
por: Li, Chaonan, et al.
Publicado: (2022)

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
por: Hsu, Ren-Jun, et al.
Publicado: (2022)

Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis
por: Zhang, Li, et al.
Publicado: (2020)

Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
por: Pelleau, Stéphane, et al.
Publicado: (2021)

Analysis of macular structure in age-related cataract patients with different antibody levels of severe acute respiratory syndrome coronavirus-2 vaccine
por: Li, Xiaochun, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2021)

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate
por: Mei, Shan, et al.
Publicado: (2022)

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
por: Choi, Hyun-Woo, et al.
Publicado: (2022)

Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2
por: Banerjee, Arinjay, et al.
Publicado: (2020)

Kinetics of Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Doses in Patients With Predominant Antibody Deficiency
por: DiGiacomo, Daniel, et al.
Publicado: (2023)

Diffuse Alveolar Hemorrhage Associated With Severe Acute Respiratory Syndrome Coronavirus 2
por: Wali, Haytham A, et al.
Publicado: (2021)

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
por: Santa Cruz, André, et al.
Publicado: (2021)

Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients with Coronavirus Disease 2019
por: Kim, Da Young, et al.
Publicado: (2021)

Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Bahar, Burak, et al.
Publicado: (2020)

An updated review of SARS‐CoV‐2 detection methods in the context of a novel coronavirus pandemic
por: Zhang, Yuxuan, et al.
Publicado: (2022)

Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease
por: Keep, Sarah, et al.
Publicado: (2022)

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
por: Yip, Ming Shum, et al.
Publicado: (2014)

Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2
por: Sajna, Kuttuvan Valappil, et al.
Publicado: (2021)

The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
por: Wang, Zhihui, et al.
Publicado: (2021)

Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021)

Duration of antibody responses following severe acute respiratory syndrome coronavirus 2 infection
por: Jiang, Yao, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome and Coronavirus
por: Hui, David S.C., et al.
Publicado: (2010)

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
por: Okba, Nisreen M.A., et al.
Publicado: (2020)

Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Subgenomic RNAs
por: Hussain, Snawar, et al.
Publicado: (2006)

Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Li, Ge, et al.
Publicado: (2021)

Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies
por: Patel, Rashmi, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses
por: Ogata, Alana F., et al.
Publicado: (2022)

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
por: Alexopoulos, Harry, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis
por: Kim, Dae Kyu, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome–associated Coronavirus Infection
por: Chan, Paul K.S., et al.
Publicado: (2003)

Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development
por: Chen, Keda, et al.
Publicado: (2021)

Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
por: Price, Susanna, et al.
Publicado: (2020)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination
por: Hettiarachchi, Ravin, et al.
Publicado: (2022)

Characteristics and roles of severe acute respiratory syndrome coronavirus 2‐specific antibodies in patients with different severities of coronavirus 19
por: Huang, Z., et al.
Publicado: (2020)

In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2
por: Westover, Jonna B, et al.
Publicado: (2020)

Sinonasal complications of severe acute respiratory syndrome coronavirus‐2: A single center case series
por: Lee, Saangyoung E., et al.
Publicado: (2023)

Coronavirus in severe acute respiratory syndrome (SARS)
por: Chan, Henry L.Y., et al.
Publicado: (2003)

Novel coronavirus and severe acute respiratory syndrome
por: Falsey, Ann R, et al.
Publicado: (2003)

Severe Acute Respiratory Syndrome Coronavirus 2
por: Marks, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cti837cc5vvlognd8tke91jme6